Device Trial Radar · NCT05237310
Comparing Detection of Standard Colonoscopy, CAD-EYE and Combined CAD-EYE and G-EYE® Aided Colonoscopy
Last checked: Nov 19, 2026Latest source record: Mar 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
372
Planned (sponsor's estimate)
Start
Feb 2, 2022
Primary completion
Aug 2022
Study completion Sep 2022
Sponsor
- Lead sponsor
- Smart Medical Systems Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Fujifilm
- First posted
- Feb 14, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the additional diagnostic yield over Standard Colonoscopy (i.e., the adenoma miss-rate reduction) obtained by performing CADEYE and G-EYE® aided colonoscopy, vs. the additional diagnostic yield over Standard Colonoscopy (i.e., the adenoma miss-rate reduction) obtained by performing CAD-EYE aided colonoscopy.
Conditions
- Colorectal Cancer
- Adenoma
Interventions
Standard ColonoscopyDevice
Standard Colonoscopy using a standard Fujifilm colonoscope
G-EYE ColonoscopyDevice
G-EYE Colonoscopy performed using SMART Medical G-EYE Colonoscope
CAD-EYEDevice
Colonoscopy performed using with the aid of Fujifilm CAD-EYE artificial intelligence
Primary outcomes
What the sponsor says the trial is designed to measure.
- Additional Adenoma DetectionTime frame: Upon histology results (up to 30 days)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbH
Wiesbaden, Germany · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.